Photo from wikipedia
e16006Background: Antiangiogenic therapy in combination with chemotherapy has shown improved clinical benefit in advanced cancer. In third-line therapy, apatinib (a TKI against VEGFR-2) has shown g... Click to show full abstract
e16006Background: Antiangiogenic therapy in combination with chemotherapy has shown improved clinical benefit in advanced cancer. In third-line therapy, apatinib (a TKI against VEGFR-2) has shown g...
Keywords:
safety apatinib;
clinical efficacy;
efficacy safety;
line;
cancer
Journal Title: Journal of Clinical Oncology
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of Clinical Oncology
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!